MedTrace Logo

Local Infiltration With Levobupivacaine During Laparoscopic Cholecystectomy

NCT04697329 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 233

Last updated 2022-05-27

No results posted yet for this study

Summary

Randomized controlled trial on laparoscopic cholecystectomy. Interventional group: preincisional infiltration with levobupivacaine. Control group: no local infiltration.

Postoperative pain with numeric rating scale is registered, besides other parameters like heart rate, blood pressure, rescue analgesia requirements, nausea and vomiting, etc.

Conditions

  • Laparoscopic Cholecystectomy
  • Postoperative Pain
  • Local Infiltration
  • Levobupivacaine

Interventions

DRUG

Preincisional infiltration with levobupivacaine

Local, preincisional infiltration of port sites with levobupivacaine 5 mg/ml 20 ml

Sponsors & Collaborators

  • Hospital Universitario de Móstoles

    lead OTHER

Principal Investigators

  • MANUEL DURÁN POVEDA, MD · H. U. REY JUAN CARLOS

  • GIL RODRÍGUEZ CARAVACA, MD · H. F. ALCORCÓN

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-03
Primary Completion
2022-05-26
Completion
2022-05-26

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04697329 on ClinicalTrials.gov